Trader’s Alert: AbbVie Inc (NYSE:ABBV), NeoStem Inc (NASDAQ:NBS), Occidental Petroleum Corporation (NYSE:OXY), Wells Fargo & Co (NYSE:WFC)

AbbVie, Inc. (NYSE:ABBV) announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need. Currently there are no approved treatments for fingernail psoriasis. AbbVie Inc (NYSE:ABBV) stock performance was 1.07% in last session and finished the day at $53.68. The average volume of the stock remained 6.26million shares. AbbVie Inc (NYSE:ABBV) insider ownership is 0.10%.

NeoStem, Inc. (Nasdaq:NBS) announced that, on March 11, 2014, the Data Safety Monitoring Board (“DSMB”) recommended continuing the PreSERVE AMI Phase 2 clinical trial following a fourth interim data and safety review. The PreSERVE trial of AMR-001 is a Phase 2, randomized, placebo controlled, double-blind study designed to enroll 160 patients. NeoStem Inc (NASDAQ:NBS) dropped -0.97 percent to $7.18. The intra-day range of the stock was $7.10 to $7.36. NeoStem Inc (NASDAQ:NBS) has a market capitalization of $205.22million.

Occidental Petroleum Corp. (NYSE:OXY) shares dropped 2.5%. Occidental said recently that it plans to split its California operations into a separate, publicly traded company. Occidental Petroleum Corporation (NYSE:OXY)’s stock on Mar 20, 2014 reported a decrease of -2.32% to the closing price of $92.93. Its fifty two weeks range is $77.21 -$99.42. The total market capitalization recorded $73.86billion. The overall volume in the last trading session was 10.00million shares. In its share capital, OXY has 802.00million outstanding shares.

Wells Fargo & Co. (NYSE:WFC) saw some unusual options trading on Thursday. Stock investors acquired 17,010 put options on the company, AR Network reports. This represents an increase of approximately 166% compared to the typical daily volume of 6,391 put options. On Thursday, shares of Wells Fargo & Co (NYSE:WFC) advanced 2.55% to close the day at $49.03. Company return on investment (ROI) is 9.80% and its monthly performance is recorded as 7.69%. Wells Fargo & Co (NYSE:WFC) quarterly revenue growth is 13.23%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone